» Authors » L K Rajeev

L K Rajeev

Explore the profile of L K Rajeev including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 136
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Abraham Jacob L, Choudhary S, Suresh Babu M, K N L, Rudresha A, Rajeev L, et al.
Indian J Hematol Blood Transfus . 2024 Oct; 40(4):588-595. PMID: 39469170
Multiple myeloma (MM) has witnessed significant therapeutic advancements through the introduction of proteasome inhibitors and immunomodulators, leading to improved treatment outcomes. However, infections remain a formidable challenge for MM patients....
3.
Patidar Y, Saldhana S, Suresh Babu M, Abraham Jacob L, Rudresh A, Lokesh K, et al.
Lung India . 2024 Aug; 41(5):375-378. PMID: 39215982
Orbital metastasis is a rare entity in oncology. With increasing awareness and advancement, patients with initial ocular presentation can be diagnosed and treated. Ocular metastasis is more common in breast...
4.
Abraham Jacob L, Begum T, Halder A, Suresh Babu M, Lokesh K, Rudresha A, et al.
Indian J Hematol Blood Transfus . 2024 Jul; 40(3):392-399. PMID: 39011262
Hodgkin's lymphoma treatment outcomes have been the true success story of modern medicine. Various data from western as well as Indian studies are available for classical Hodgkin's lymphoma (cHL). Here...
5.
Saldanha S, Goyal S, Dasappa L, Abraham Jacob L, Suresh Babu M, Lokesh K, et al.
Int J Hematol Oncol Stem Cell Res . 2023 Jan; 16(3):184-188. PMID: 36694704
Multiple myeloma constitutes a wide spectrum of diseases, ranging from slow-growing monoclonal gammopathy of undetermined significance to rapidly progressing plasma cell leukemia. It is a very rarely diagnosed hematological malignancy...
6.
Siddappa S, Hassan S, Lingappa K, Prasannakumari , Rajeev L, Padma M, et al.
Indian J Hematol Blood Transfus . 2022 Oct; 38(4):739-744. PMID: 36258729
Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-022-01525-1.
7.
Rudresha A, Hassan S, Sreevalli A, Lokanatha D, Suresh Babu M, Lokesh K, et al.
J Egypt Natl Canc Inst . 2022 May; 34(1):20. PMID: 35527285
Context: Treatment-related toxicities in DLBCL (diffuse large B cell lymphoma) patients are higher in the initial phase of treatment (first cycle effect). Implementation of pre-phase treatment before definitive chemotherapy had...
8.
Moharana L, Dasappa L, Babu S, Lokesh K, Rudresh A, Rajeev L, et al.
Indian J Hematol Blood Transfus . 2022 Feb; 38(1):15-23. PMID: 35125708
Lymphoma that on morphology appear blastoid or intermediate between DLBCL and BL but who lack myc and bcl-2 and/or bcl-6 rearrangements are grouped under high grade B-cell lymphoma, not otherwise...
9.
Rudresha A, Sansar B, Lokanath D, Abraham Jacob L, Suresh Babu M, Lokesh K, et al.
South Asian J Cancer . 2021 Dec; 10(3):190-194. PMID: 34938684
Bone marrow aspiration although being a common procedure is associated with significant pain and its reduction remains an unmet need. We evaluated the use of tramadol and eutectic mixture of...
10.
Rudreshaa A, Goyal S, Lokanatha D, Abraham Jacob L, Lokesh K, Saldanha S, et al.
South Asian J Cancer . 2021 Oct; 10(2):115-119. PMID: 34595141
Follicular lymphoma (FL) is a disease of the elderly. It is postulated that younger patients have distinct tumor biology and treatment outcomes. Various lymphoma groups across the world have studied...